Influence of Closed Suction Drainage After Total Knee Replacement. (TKR)

October 5, 2021 updated by: Artur Stolarczyk, Medical University of Warsaw

Influence of Closed Suction Drainage After Total Knee Replacement on Patient's Reported Outcome and Basic Morphology Results, and Inflammation Factors

The aim of the study will be to compare functional outcomes, basic morphology results, number of blood transfusions, costs of hospitalization, and inflammation factors, following total knee replacement (with use of one type of endoprosthesis) comparing use of closed suction drainage (CSD). Use of closed suction drainage may have influence on patients functional outcome.

Study Overview

Detailed Description

Patients with primary knee osteoarthritis will be included in a randomized controlled trial and assigned to total knee arthroplasty with or without closed suction drainage. Subjects will be evaluated preoperatively, 1-day, 3-, 6- and 12-month postoperatively.

Change in morphology results will be measured by comparing preoperative and postoperative levels of haematocrite, haemoglobin, erythrocytes, and platelets.

Change in the number of blood transfusions will be measured by analyzing the number of needed transfusion of packed red blood cells in the postoperative period during stay in the hospital.

Change in levels of inflammation factors will be measured by analyzing the level of C-reactive protein in first and third day postoperatively.

Change in body temperature wille be measured daily by analyzing body temperature from day of the surgery until the day of discharge from the hospital

Presence of haematoma will be evaluated daily in the postoperative period by clinical examination.

Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score will be measured from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively

Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score will be measured from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively

Costs of hospitalization will be measured by comparing cost of hospitalization between two analyzed groups

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient's consent for anticipation in the study
  • arthroplasty in one knee

Exclusion Criteria:

  • patient's lack of consent for anticipation in the study
  • haematological diseases
  • reoperations in the area of endoprosthesis
  • medical history of any surgical intervention on the lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Total knee replacement with use of closed suction drainage
Use of closed suction drainage following total knee replacement in treatment of knee primary osteoarthritis
Use of closed suction drainage following total knee arthroplasty
Other Names:
  • Redon's drain
ACTIVE_COMPARATOR: Total knee replacement without use of closed suction drainage
Without the use of closed suction drainage following total knee replacement in treatment of knee primary osteoarthritis
Abstain of using a closed suction drainage following total knee arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in haematocrite levels
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Measuring results of haematocrite (in percentage in 1 ml of blood sample)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in the number of blood transfusions
Time Frame: from baseline to the 1-,2-,3- days postoperatively
Measuring the number of needed transfusion of packed red blood cells in the postoperative period
from baseline to the 1-,2-,3- days postoperatively
Change in levels of inflammation factors
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Measuring the level of C-reactive protein
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in haemoglobin levels
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Measuring results of haemoglobin (g/dL)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in erythrocytes levels
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Measuring results of erythrocytes (number/ml)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in platelets levels
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Measuring results of platelets (number/ml)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score from baseline
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively
The WOMAC Pain score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Pain scores range from 0-100 with lower scores considered lower pain.
from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score from baseline
Time Frame: from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively
The WOMAC Function score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Function scores range from 0-100 with lower scores considered to have better function.
from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively
Change in body temperature
Time Frame: from baseline to the 1-,2-,3- days postoperatively
Measuring body temperature from day of the surgery to the hospital until the day of discharge from the hospital
from baseline to the 1-,2-,3- days postoperatively
Influence of using CSD on costs of hospitalization
Time Frame: from baseline to the one year postoperatively
Comparing cost of hospitalization between two analyzed groups
from baseline to the one year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Artur Stolarczyk, MD, PhD, Medical University of Warsaw
  • Principal Investigator: Marcin Wojewodzki, Medical University of Warsaw

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

March 1, 2022

Primary Completion (ANTICIPATED)

November 2, 2022

Study Completion (ANTICIPATED)

March 1, 2023

Study Registration Dates

First Submitted

April 25, 2019

First Submitted That Met QC Criteria

June 20, 2019

First Posted (ACTUAL)

June 21, 2019

Study Record Updates

Last Update Posted (ACTUAL)

October 6, 2021

Last Update Submitted That Met QC Criteria

October 5, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • TKR/ Warsaw MU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Replacement

Clinical Trials on Use of closed suction drainage following total knee arthroplasty

Subscribe